Melody Transcatheter Pulmonary Valve
Medtronic, Inc. · Decision date Feb 12, 2026
What did the FDA approve?
FDA records P140017/S033 as a supplement to PMA P140017, with the supplement type “135 Review Track For 30-Day Notice”. The recorded decision is approval, dated Feb 12, 2026.
FDA approval order statement
approval for a Pre-Determined Change Control Plan (PCCP) that establishes a standardized qualification process for new bovine and porcine tissue suppliers, provided they do not impact the tissue's specifications, the established methods for its sourcing, handling, and testing, or the qualification standards for supplier facilities and personnel for the devices under the above PMAs
- Regulatory pathway
- PMA supplement
- Supplement type
- 135 Review Track For 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 12, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P140017/S033
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- NPV
- Decision code
- APPR
- Decision date
- Feb 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulmonary valve prosthesis percutaneously delivered.
- Applicant
- Medtronic, Inc.
- Product code
- NPV
- FDA device class
- f
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P140017/S031 · Related supplement
Melody Transcatheter Pumonary Valve System
P140017/S033 received
Application receipt date recorded by FDA.
P140017/S032 · Related supplement
Melody Transcatheter Pulmonary Valve
P140017/S033 · FDA decision
135 Review Track For 30-Day Notice
P140017/S034 · Related supplement
Melody Transcatheter Pulmonary Valve
P140017/S036 · Related supplement
Melody Transcatheter Pulmonary Valve
P140017/S035 · Related supplement
Melody Transcatheter Pulmonary Valve System, which includes the Melody Transcatheter Pulmonary Valve (Melody TPV) and th
Timeline entries are records held by MedtechLedger for P140017. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140017
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Melody Transcatheter Pumonary Valve SystemP140017/S031 | Medtronic, Inc. | PMA supplement | Aug 21, 2025 | FDA |
Melody Transcatheter Pulmonary ValveP140017/S032 | Medtronic, Inc. | PMA supplement | Oct 23, 2025 | FDA |
Melody Transcatheter Pulmonary ValveP140017/S034 | Medtronic, Inc. | PMA supplement | Apr 9, 2026 | FDA |
Melody Transcatheter Pulmonary ValveP140017/S036 | Medtronic, Inc. | PMA supplement | Jun 1, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Jun 9, 2026 | FDA |
Explore the linked device profile
Other records with product code NPV
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 27, 2026 | FDA | |
Harmony TPV SystemP200046/S052 | Medtronic, Inc. | PMA supplement | Sep 30, 2026 | FDA |
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. NE Mvs83, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P140017/S033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


